Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / Class A Common Stock, par value $0.01 per share
-
Shares outstanding
-
144,919,287
-
Total 13F shares
-
97,444,087
-
Share change
-
+69,302,601
-
Total reported value
-
$2,733,175,243
-
Put/Call ratio
-
8.2%
-
Price per share
-
$28.05
-
Number of holders
-
112
-
Value change
-
+$1,943,807,357
-
Number of buys
-
110
Institutional Holders of MARAVAI LIFESCIENCES HOLDINGS, INC. - Class A Common Stock, par value $0.01 per share (MRVI) as of Q4 2020
As of 31 Dec 2020,
MARAVAI LIFESCIENCES HOLDINGS, INC. - Class A Common Stock, par value $0.01 per share (MRVI) was held by
112 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
97,444,087 shares.
The largest 10 holders included
GTCR LLC, D1 Capital Partners L.P., FMR LLC, VANGUARD GROUP INC, MASSACHUSETTS FINANCIAL SERVICES CO /MA/, JPMORGAN CHASE & CO, Invesco Ltd., UBS ASSET MANAGEMENT AMERICAS INC, Avidity Partners Management LP, and LAZARD ASSET MANAGEMENT LLC.
This page lists
114
institutional shareholders reporting positions in this security
for the Q4 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.